PLC-beta-IN-1 (Compound 8a) is an inhibitor of PLCbeta that exhibits anti-airway constriction activity by suppressing PLCbeta and its downstream signaling pathways. It also enhances the bronchorelaxant effects of beta-agonists. This compound can be utilized in asthma research.
Target:
Phospholipase
* VAT and and shipping costs not included. Errors and price changes excepted
